Patents by Inventor Karen Kage

Karen Kage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multimeric IL-15-based molecules
    Patent number: 11369679
    Abstract: The invention features multi-specific protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to a disease antigen, immune checkpoint or signaling molecule.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: June 28, 2022
    Assignee: Altor Bioscience, LLC
    Inventors: Hing C. Wong, Warren Marcus, Bai Liu, Wenxin Xu, Robert Newman, Karen Kage, Lijing You, Peter Rhode, Patrick Soon-Shiong
  • Multimeric IL-15-based molecules
    Patent number: 11318201
    Abstract: The invention features multi-specific protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to a disease antigen, immune checkpoint or signaling molecule.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: May 3, 2022
    Assignee: Altor Bioscience, LLC.
    Inventors: Hing C. Wong, Warren Marcus, Bai Liu, Wenxin Xu, Robert G. Newman, Karen Kage, Lijing You, Peter Rhode, Patrick Soon-Shiong
  • Multimeric IL-15-based molecules
    Patent number: 11197929
    Abstract: The invention features multi-specific protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to a disease antigen, immune checkpoint or signaling molecule.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: December 14, 2021
    Assignees: NantCell, Inc., Altor BioScience, LLC.
    Inventors: Hing C. Wong, Warren Marcus, Bai Liu, Wenxin Xu, Robert G. Newman, Karen Kage, Lijing You, Peter Rhode, Patrick Soon-Shiong
  • MULTIMERIC IL-15-BASED MOLECULES
    Publication number: 20210196821
    Abstract: The invention features multi-specific protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to a disease antigen, immune checkpoint or signaling molecule.
    Type: Application
    Filed: January 29, 2021
    Publication date: July 1, 2021
    Inventors: Hing C. WONG, Warren MARCUS, Bai LIU, Wenxin XU, Robert G NEWMAN, Karen KAGE, Lijing YOU, Peter RHODE, Patrick SOON-SHIONG
  • MULTIMERIC IL-15-BASED MOLECULES
    Publication number: 20200261575
    Abstract: The invention features multi-specific protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to a disease antigen, immune checkpoint or signaling molecule.
    Type: Application
    Filed: January 24, 2020
    Publication date: August 20, 2020
    Inventors: Hing C. Wong, Warren Marcus, Bai Liu, Wenxin Xu, Robert Newman, Karen Kage, Lijing You, Peter Rhode, Patrick Soon-Shiong
  • MULTIMERIC IL-15-BASED MOLECULES
    Publication number: 20180200366
    Abstract: The invention features multi-specific protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to a disease antigen, immune checkpoint or signaling molecule.
    Type: Application
    Filed: October 21, 2017
    Publication date: July 19, 2018
    Inventors: Hing C. Wong, Warren Marcus, Bai Liu, Wenxin Xu, Robby Newman, Karen Kage, Lijing You, Peter Rhode, Patrick Soon-Shiong
  • ISOINDOLINONE KINASE INHIBITORS
    Publication number: 20110275630
    Abstract: Compounds having the formula: are useful for inhibiting protein kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    Type: Application
    Filed: November 3, 2010
    Publication date: November 10, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Mark Matulenko, Tammie Jinkerson, Brian S. Brown, Wilfried Braje, Michael Curtin, Howard Robin Heyman, Victoria Scott, Karen Kage, Steven Cassar, Anil Vasudevan